Riskpilot← Back to searchSign inGet full accessImmuno Diagnostic Oy
OYActiveY-tunnus 0499964-0Kaivokatu 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198323 employees
Revenue 2024
EUR 10,2M
-17% vs 2022
EBITDA margin
10.4%
-28% vs 2022
Equity ratio
47.5%
Financial strength
Net profit 2024
EUR 604K
-38% vs 2022
| Revenue | EUR 10,2M | -17% |
| EBITDA | EUR 1,1M | -28% |
| Net profit | EUR 604K | -38% |
| Total assets | EUR 4,9M | -26% |
| Equity | EUR 2,3M | +3% |
| Employees | 23 | — |
Legal name
Immuno Diagnostic Oy
Y-tunnus number
0499964-0
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. helmikuuta 1983
Share capital
EUR 12 362
Employees
23 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveydenhuoltoalalla, teollisuudessa ja tutkimustoiminnassa käytettävien laitteiden, kulutustavaroiden, reagenssien sekä diagnostisten tuotteiden valmistus, maahantuonti, myynti ja vienti ja lääkeaineiden maahantuonti, myynti ja vienti sekä näiden alojen huolto ja konsultointi. Yhtiö voi omistaa, vuokrata ja hallita kiinteistöjä ja osakehuoneistoja sekä käydä kauppaa arvopapereilla.
Address
Kaivokatu 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 233 | 19 745 | 18 342 | 12 169 | 10 161 |
| Staff expenses | −2 477 | −2 761 | −2 561 | −2 181 | −1 834 |
| EBITDA | 1 994 | 3 466 | 3 221 | 1 480 | 1 060 |
| Depreciation & amort. | −165 | −161 | −244 | −238 | −274 |
| EBIT | 1 829 | 3 305 | 2 977 | 1 242 | 786 |
| Net financials | −1 | −1 | 0 | −2 | 19 |
| Profit before tax | 1 828 | 3 304 | 2 978 | 1 240 | 805 |
| Tax | 368 | 662 | 613 | 261 | 201 |
| Net profit | 1 460 | 2 642 | 2 365 | 980 | 604 |
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 301 | 8 067 | 7 648 | 6 554 | 4 863 |
| Equity | 2 650 | 3 592 | 3 657 | 2 237 | 2 311 |
| Long-term debt | 175 | 160 | 79 | 122 | 0 |
| Short-term debt | 2 477 | 4 315 | 3 912 | 4 196 | 2 552 |
| Total debt | 2 651 | 4 475 | 3 991 | 4 317 | 2 552 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20192024
Equity ratio
47.5%
This company
38.2%
Market median
+24% vs market
20192024
Return on equity
26.2%
This company
18.4%
Market median
+42% vs market
20192024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20192024
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20192024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
JA Chief Executive Officer | Chief Executive Officer | 2015 – 2021 |
TI Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
TM Audit | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Chairperson | 2020 | |
| Former (2) | ||
| Board of Directors | 2018 – 2024 | |
| Chairperson | 2018 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Immuno Diagnostic Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jarmo Antero Laakkonen | Chief Executive Officer | 0 companies |
| Tomi Ilmari Virtanen | Chief Executive Officer | 0 companies |
| Toni Mikael Ramu | Audit | 0 companies |
| Malin Amanda Cecilia Lindh | Board of Directors | 0 companies |
| Peter Mikael Simonsbacka | Board of Directors | 0 companies |
| Per Anders Wahlstedt | Board of Directors | 0 companies |
| Kai Tapani Rantanen | Chairperson | 0 companies |
| Rolf Ove Stefan Sandin | Chairperson | 0 companies |